Innovator’s Pitch Challenge

Vote for Me

Interested in Connecting? Please contact:
Dr. Alexei Mlodinow
Co-founder and CEO
alexei@sia.health

Message the company or request a 1:1 meeting here

Surgical Innovation Associates (SIA) is a Chicago-based medical device spin-out from Northwestern University with FDA 510(k) clearance, CE Mark, and rapidly growing sales for its first product, DuraSorbâ„¢ – a patented absorbable surgical mesh in the $1B+ general and reconstructive surgery market. In only a few months on the market, we have grown sales to >$100k/month at >80% gross profit margin. SIA is led by an industry-experienced management team and supported by a veteran Board of Directors as well as a reputable medical advisory board. Existing investors include ex-CEO’s and CFO’s of publicly traded medical device corporations (Baxter Healthcare, Baxalta, etc.), KOL surgeons from leading universities (Northwestern, NYU, Northshore) and respected angel groups from across the country (Harvard Business School Angels, Gopher Angels, Ann Arbor Angels). We’ve also received $2M of NCI SBIR grants with an opportunity for $4M of follow-on grant funding, providing investors with great leverage. We are now seeking a $10M Series B predominantly to fuel sales growth, with a target closing in Q1 2021